Leukotriene	O
B4	O
stimulates	O
c-fos	O
and	O
c-jun	O
gene	O
transcription	O
and	O
AP-1	B-protein
binding	O
activity	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

We	O
have	O
examined	O
the	O
effect	O
of	O
leukotriene	O
B4	O
(	O
LTB4	O
)	O
,	O
a	O
potent	O
lipid	O
proinflammatory	B-protein
mediator	I-protein
,	O
on	O
the	O
expression	O
of	O
the	O
proto-oncogenes	B-DNA
c-jun	I-DNA
and	I-DNA
c-fos	I-DNA
.	O

In	O
addition	O
,	O
we	O
looked	O
at	O
the	O
modulation	O
of	O
nuclear	B-protein
factors	I-protein
binding	O
specifically	O
to	O
the	O
AP-1	B-DNA
element	I-DNA
after	O
LTB4	O
stimulation	O
.	O

LTB4	O
increased	O
the	O
expression	O
of	O
the	O
c-fos	B-DNA
gene	I-DNA
in	O
a	O
time-	O
and	O
concentration-dependent	O
manner	O
.	O

The	O
c-jun	B-RNA
mRNA	I-RNA
,	O
which	O
is	O
constitutively	O
expressed	O
in	O
human	B-cell_type
peripheral-blood	I-cell_type
monocytes	I-cell_type
at	O
relatively	O
high	O
levels	O
,	O
was	O
also	O
slightly	O
augmented	O
by	O
LTB4	O
,	O
although	O
to	O
a	O
much	O
lower	O
extent	O
than	O
c-fos	B-DNA
.	O

The	O
kinetics	O
of	O
expression	O
of	O
the	O
two	O
genes	O
were	O
also	O
slightly	O
different	O
,	O
with	O
c-fos	B-RNA
mRNA	I-RNA
reaching	O
a	O
peak	O
at	O
15	O
min	O
after	O
stimulation	O
and	O
c-jun	B-DNA
at	O
30	O
min	O
.	O

Both	O
messages	O
rapidly	O
declined	O
thereafter	O
.	O

Stability	O
of	O
the	O
c-fos	B-DNA
and	O
c-jun	B-RNA
mRNA	I-RNA
was	O
not	O
affected	O
by	O
LTB4	O
,	O
as	O
assessed	O
after	O
actinomycin	O
D	O
treatment	O
.	O

Nuclear	O
transcription	O
studies	O
in	O
vitro	O
showed	O
that	O
LTB4	O
increased	O
the	O
transcription	O
of	O
the	O
c-fos	B-DNA
gene	I-DNA
7-fold	O
and	O
the	O
c-jun	B-DNA
gene	I-DNA
1.4-fold	O
.	O

Resting	B-cell_type
monocytes	I-cell_type
contained	O
nuclear	B-protein
factors	I-protein
binding	O
to	O
the	O
AP-1	B-DNA
element	I-DNA
,	O
but	O
stimulation	O
of	O
monocytes	B-cell_type
with	O
LTB4	O
induced	O
greater	O
AP-1	B-protein
-binding	O
activity	O
of	O
nuclear	B-protein
proteins	I-protein
.	O

These	O
results	O
indicate	O
that	O
LTB4	O
may	O
regulate	O
the	O
production	O
of	O
different	O
cytokines	B-protein
by	O
modulating	O
the	O
yield	O
and/or	O
the	O
function	O
of	O
transcription	B-protein
factors	I-protein
such	O
as	O
AP-1	B-protein
-binding	O
proto-oncogene	B-protein
products	I-protein
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
282	NULL
,	NULL
625-629	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
RESEARCH	NULL
COMMUNICATION	NULL
625	NULL
Leukotriene	NULL
B	NULL
,	NULL
stimulates	NULL
c-fos	NULL
and	NULL
c-jun	NULL
gene	NULL
transcription	NULL
and	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
Jana	NULL
STANKOVA	NULL
and	NULL
Marek	NULL
ROLA-PLESZCZYNSKI	NULL
Immunology	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Sherbrooke	NULL
,	NULL
3001	NULL
12th	NULL
Avenue	NULL
North	NULL
,	NULL
Sherbrooke	NULL
,	NULL
Qu√©bec	NULL
,	NULL
Canada	NULL
J1H	NULL
SN4	NULL
We	NULL
have	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
leukotriene	NULL
B	NULL
,	NULL
(	NULL
LT	NULL
B	NULL
,	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
lipid	NULL
proinflammatory	NULL
mediator	NULL
,	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
proto-oncogenes	NULL
c-jun	NULL
and	NULL
c-fos	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
looked	NULL
at	NULL
the	NULL
modulation	NULL
of	NULL
nuclear	NULL
factors	NULL
binding	NULL
specifically	NULL
to	NULL
the	NULL
AP-1	NULL
element	NULL
after	NULL
LTB	NULL
,	NULL
stimulation	NULL
.	NULL

LTB	NULL
,	NULL
increased	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
in	NULL
a	NULL
time-	NULL
and	NULL
concentration-dependent	NULL
manner	NULL
.	NULL

The	NULL
c-jun	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
human	NULL
peripheral-blood	NULL
monocytes	NULL
at	NULL
relatively	NULL
high	NULL
levels	NULL
,	NULL
was	NULL
also	NULL
slightly	NULL
augmented	NULL
by	NULL
LTB	NULL
,	NULL
,	NULL
although	NULL
to	NULL
a	NULL
much	NULL
lower	NULL
extent	NULL
than	NULL
c-fos	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
genes	NULL
were	NULL
also	NULL
slightly	NULL
different	NULL
,	NULL
with	NULL
c-fos	NULL
mRNA	NULL
reaching	NULL
a	NULL
peak	NULL
at	NULL
15	NULL
min	NULL
after	NULL
stimulation	NULL
and	NULL
c-jun	NULL
at	NULL
30	NULL
min	NULL
.	NULL

Both	NULL
messages	NULL
rapidly	NULL
declined	NULL
thereafter	NULL
.	NULL

Stability	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
LTB	NULL
,	NULL
,	NULL
as	NULL
assessed	NULL
after	NULL
actinomycin	NULL
D	NULL
treatment	NULL
.	NULL

Nuclear	NULL
transcription	NULL
studies	NULL
in	NULL
vitro	NULL
showed	NULL
that	NULL
LTB	NULL
,	NULL
increased	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
7-fold	NULL
and	NULL
the	NULL
c-jun	NULL
gene	NULL
1.4-fold	NULL
.	NULL

Resting	NULL
monocytes	NULL
contained	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
_	NULL
the	NULL
AP-1	NULL
element	NULL
,	NULL
but	NULL
stimulation	NULL
of	NULL
monocytes	NULL
with	NULL
LTB	NULL
,	NULL
induced	NULL
greater	NULL
AP-1-binding	NULL
activity	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
LTB	NULL
,	NULL
may	NULL
regulate	NULL
the	NULL
production	NULL
of	NULL
different	NULL
cytokines	NULL
by	NULL
modulating	NULL
the	NULL
yield	NULL
and/or	NULL
the	NULL
function	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1-binding	NULL
proto-oncogene	NULL
products	NULL
.	NULL

INTRODUCTION	NULL
Leukotriene	NULL
B	NULL
,	NULL
(	NULL
LTB	NULL
,	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
biologically	NULL
active	NULL
lipid	NULL
mediator	NULL
which	NULL
exerts	NULL
numerous	NULL
proinflammatory	NULL
and	NULL
immuno-regulatory	NULL
activities	NULL
[	NULL
1-6	NULL
]	NULL
.	NULL

Its	NULL
production	NULL
by	NULL
polymorphonuclear	NULL
and	NULL
mononuclear	NULL
leucocytes	NULL
can	NULL
be	NULL
triggered	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
reviewed	NULL
in	NULL
[	NULL
2	NULL
]	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
which	NULL
produce	NULL
it	NULL
can	NULL
also	NULL
be	NULL
targets	NULL
of	NULL
its	NULL
bioactions	NULL
.	NULL

In	NULL
monocytes	NULL
,	NULL
exogenous	NULL
LTB	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
stimulate	NULL
H	NULL
,	NULL
O	NULL
,	NULL
production	NULL
as	NULL
well	NULL
as	NULL
cytotoxicity	NULL
against	NULL
tumour	NULL
cells	NULL
[	NULL
7,8	NULL
]	NULL
.	NULL

Moreover	NULL
,	NULL
LTB	NULL
,	NULL
could	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
tumour	NULL
necrosis	NULL
factor	NULL
a	NULL
[	NULL
8	NULL
]	NULL
and	NULL
interleukin	NULL
6	NULL
[	NULL
9	NULL
]	NULL
.	NULL

Endogenous	NULL
5-lipoxygenase	NULL
metabolites	NULL
,	NULL
including	NULL
LTB	NULL
,	NULL
,	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
signals	NULL
for	NULL
cytokine	NULL
production	NULL
stimulated	NULL
by	NULL
other	NULL
ligands	NULL
,	NULL
such	NULL
as	NULL
platelet-activating	NULL
factor	NULL
[	NULL
10	NULL
]	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin-6	NULL
,	NULL
can	NULL
be	NULL
mediated	NULL
by	NULL
nuclear	NULL
protein	NULL
trans-acting	NULL
factors	NULL
which	NULL
bind	NULL
to	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
of	NULL
gene	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
AP-1	NULL
[	NULL
11-13	NULL
]	NULL
.	NULL

AP-1-binding	NULL
factors	NULL
include	NULL
the	NULL
heterodimeric	NULL
complex	NULL
of	NULL
FOS	NULL
and	NULL
JUN	NULL
proteins	NULL
[	NULL
14	NULL
]	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
products	NULL
of	NULL
the	NULL
proto-oncogenes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
respectively	NULL
,	NULL
which	NULL
become	NULL
trans-criptionally	NULL
active	NULL
within	NULL
minutes	NULL
after	NULL
extracellular	NULL
signals	NULL
and	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
containing	NULL
AP-l-binding	NULL
sites	NULL
{	NULL
15-18	NULL
]	NULL
.	NULL

Thus	NULL
extracellular	NULL
signals	NULL
and	NULL
their	NULL
receptors	NULL
can	NULL
be	NULL
linked	NULL
to	NULL
eventual	NULL
cytokine	NULL
production	NULL
by	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
which	NULL
may	NULL
include	NULL
transcriptional	NULL
activation	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
,	NULL
production	NULL
of	NULL
FOS-JUN	NULL
proteins	NULL
and	NULL
binding	NULL
to	NULL
AP-l-con-taining	NULL
cytokine	NULL
genes	NULL
,	NULL
which	NULL
would	NULL
then	NULL
trigger	NULL
transcriptional	NULL
activation	NULL
of	NULL
these	NULL
genes	NULL
and	NULL
stimulation	NULL
of	NULL
production	NULL
of	NULL
the	NULL
cytokines	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
lipid	NULL
mediator	NULL
LTB	NULL
,	NULL
can	NULL
indeed	NULL
stimulate	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
and	NULL
we	NULL
suggest	NULL
that	NULL
this	NULL
may	NULL
constitute	NULL
a	NULL
mechanism	NULL
through	NULL
which	NULL
it	NULL
can	NULL
affect	NULL
transcriptional	NULL
regulation	NULL
of	NULL
AP-1-containing	NULL
target	NULL
genes	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Reagents	NULL
LTB	NULL
,	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Ford-Hutchinson	NULL
(	NULL
Merck-Frosst	NULL
,	NULL
Pointe-Claire	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

LTB	NULL
,	NULL
w-oxidation	NULL
metabolites	NULL
20-OH-LTB	NULL
,	NULL
and	NULL
20-COOH-LTB	NULL
,	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
P.	NULL
Poubelle	NULL
(	NULL
Laval	NULL
University	NULL
,	NULL
Ste.-Foy	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
monocytes	NULL
Human	NULL
venous	NULL
blood	NULL
from	NULL
healthy	NULL
medication-free	NULL
volunteers	NULL
was	NULL
collected	NULL
on	NULL
citrate/dextrose/adenine	NULL
.	NULL

Undiluted	NULL
blood	NULL
was	NULL
layered	NULL
over	NULL
a	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Baie	NULL
d'Urfe	NULL
,	NULL
QC	NULL
,	NULL
Canada	NULL
)	NULL
cushion	NULL
and	NULL
centrifuged	NULL
at	NULL
800g	NULL
for	NULL
30	NULL
min	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Boyum	NULL
[	NULL
19	NULL
]	NULL
.	NULL

Monocytes	NULL
were	NULL
then	NULL
purified	NULL
by	NULL
adherence	NULL
to	NULL
the	NULL
surface	NULL
of	NULL
plastic	NULL
Petri	NULL
dishes	NULL
previously	NULL
coated	NULL
with	NULL
baby-hamster-kidney-cell	NULL
micro-exudate	NULL
.	NULL

This	NULL
was	NULL
effective	NULL
in	NULL
enriching	NULL
the	NULL
adherent	NULL
population	NULL
to	NULL
>	NULL
90	NULL
%	NULL
monocytes	NULL
as	NULL
assessed	NULL
by	NULL
non-specific	NULL
esterase	NULL
staining	NULL
.	NULL

This	NULL
population	NULL
was	NULL
removed	NULL
with	NULL
EDTA	NULL
(	NULL
0.01	NULL
M	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
medium/5	NULL
%	NULL
fetal-bovine	NULL
serum	NULL
(	NULL
Flow	NULL
,	NULL
McLean	NULL
,	NULL
VA	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
'rested	NULL
'	NULL
overnight	NULL
in	NULL
polypropylene	NULL
tubes	NULL
(	NULL
15	NULL
ml	NULL
;	NULL
Becton-Dickinson	NULL
Labware	NULL
,	NULL
Lincoln	NULL
Park	NULL
,	NULL
NJ	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

Since	NULL
LTB	NULL
,	NULL
was	NULL
dissolved	NULL
in	NULL
methanol	NULL
before	NULL
dilution	NULL
in	NULL
culture	NULL
medium	NULL
,	NULL
control	NULL
cultures	NULL
contained	NULL
methanol	NULL
in	NULL
equivalent	NULL
maximal	NULL
concentration	NULL
,	NULL
which	NULL
never	NULL
exceeded	NULL
0.01	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
and	NULL
had	NULL
no	NULL
effect	NULL
in	NULL
the	NULL
assays	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Abbreviations	NULL
used	NULL
:	NULL
LTB	NULL
,	NULL
,	NULL
leukotriene	NULL
B	NULL
,	NULL
;	NULL
SSC	NULL
,	NULL
saline/sodium	NULL
citrate	NULL
(	NULL
for	NULL
composition	NULL
,	NULL
see	NULL
the	NULL
text	NULL
)	NULL
.	NULL

Vol	NULL
.	NULL

282	NULL
626	NULL
Research	NULL
Communication	NULL
(	NULL
a	NULL
)	NULL
(	NULL
b	NULL
)	NULL
1	NULL
2	NULL
4	NULL
5	NULL
6	NULL
to	NULL
-a	NULL
28	NULL
S	NULL
co-	NULL
@	NULL
the	NULL
alse	NULL
he	NULL
122439448	NULL
$	NULL
8	NULL
c-fos	NULL
¬Æ	NULL
Ô¨Ç	NULL
-	NULL
<	NULL
28	NULL
S	NULL
-a	NULL
28	NULL
5	NULL
wit	NULL
ma	NULL
mwa	NULL
c-jun	NULL
¬ª	NULL
*	NULL
%	NULL
#	NULL
#	NULL
#	NULL
%	NULL
UB	NULL
-	NULL
¬ª	NULL
an	NULL
x	NULL
-	NULL
<	NULL
18	NULL
S	NULL
*	NULL
.	NULL

-	NULL
<	NULL
18	NULL
S	NULL
c-jun	NULL
¬ª	NULL
#	NULL
Wierik	NULL
gm	NULL
|	NULL
|	NULL
S	NULL
-	NULL
<	NULL
18	NULL
S	NULL
1	NULL
4	NULL
ms	NULL
mle	NULL
9	NULL
K	NULL
&	NULL
44	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
LTB	NULL
,	NULL
on	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
Northern-blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Monocytes	NULL
were	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
(	NULL
1	NULL
)	NULL
0.003	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
methanol	NULL
(	NULL
vehicle	NULL
for	NULL
LTB	NULL
,	NULL
)	NULL
,	NULL
(	NULL
2	NULL
)	NULL
10~	NULL
``	NULL
m-LTB	NULL
,	NULL
,	NULL
(	NULL
3	NULL
)	NULL
10~	NULL
``	NULL
m-LTB	NULL
,	NULL
,	NULL
(	NULL
4	NULL
)	NULL
10~¬Æ	NULL
m-LTB	NULL
,	NULL
and	NULL
(	NULL
5	NULL
)	NULL
10~¬Æ	NULL
m-LTB	NULL
,	NULL
.	NULL

(	NULL
6	NULL
)	NULL
Monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
vehicle	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
and	NULL
5	NULL
)	NULL
or	NULL
LTB	NULL
,	NULL
at	NULL
10~¬Æ	NULL
m	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
and	NULL
6	NULL
)	NULL
for	NULL
different	NULL
time	NULL
periods	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
for	NULL
15	NULL
min	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
for	NULL
30	NULL
min	NULL
and	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
for	NULL
60	NULL
min	NULL
)	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Monocytes	NULL
were	NULL
used	NULL
directly	NULL
after	NULL
overnight	NULL
incubation	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
without	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
LTB	NULL
,	NULL
at	NULL
10~¬Æ	NULL
m.	NULL
In	NULL
(	NULL
b	NULL
)	NULL
and	NULL
(	NULL
c	NULL
)	NULL
the	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
c-fos	NULL
,	NULL
then	NULL
stripped	NULL
of	NULL
the	NULL
probe	NULL
and	NULL
rehybridized	NULL
with	NULL
c-jun-specific	NULL
probe	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
exposed	NULL
for	NULL
20	NULL
h	NULL
at	NULL
-80	NULL
¬∞C	NULL
.	NULL

mRNA	NULL
studies	NULL
After	NULL
appropriate	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
pelleted	NULL
in	NULL
15	NULL
ml	NULL
polypropylene	NULL
tubes	NULL
(	NULL
Sarstedt	NULL
,	NULL
St.-Laurent	NULL
,	NULL
QC	NULL
,	NULL
Canada	NULL
)	NULL
and	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
acid	NULL
guanidium	NULL
thiocyanate/	NULL
phenol/chloroform	NULL
extraction	NULL
as	NULL
described	NULL
by	NULL
Chomczynski	NULL
&	NULL
Sacchi	NULL
[	NULL
20	NULL
]	NULL
.	NULL

RNA	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
and	NULL
transferred	NULL
on	NULL
to	NULL
a	NULL
Hybond-N	NULL
(	NULL
Amersham	NULL
,	NULL
Oakville	NULL
,	NULL
Ont	NULL
.	NULL

,	NULL
Canada	NULL
)	NULL
membrane	NULL
for	NULL
Northern	NULL
analysis	NULL
.	NULL

The	NULL
cDNA	NULL
probes	NULL
used	NULL
were	NULL
a	NULL
2.7	NULL
kb	NULL
Xhol/Stu	NULL
insert	NULL
of	NULL
c-fos	NULL
[	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
A.T.C.C	NULL
.	NULL
)	NULL

]	NULL
and	NULL
a	NULL
0.9	NULL
kb	NULL
Pst	NULL
insert	NULL
of	NULL
c-jun	NULL
(	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
C.	NULL
Asselin	NULL
of	NULL
this	NULL
University	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
labelled	NULL
with	NULL
multiprime	NULL
DNA-labelling	NULL
system	NULL
(	NULL
Amersham	NULL
International	NULL
)	NULL
,	NULL
using	NULL
[	NULL
¬´	NULL
-*¬∞P	NULL
]	NULL
dCTP	NULL
(	NULL
specific	NULL
radioactivity	NULL
>	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
for	NULL
4	NULL
h	NULL
in	NULL
a	NULL
mixture	NULL
containing	NULL
Tris	NULL
(	NULL
120	NULL
mm	NULL
)	NULL
,	NULL
NaCl	NULL
(	NULL
600	NULL
mm	NULL
)	NULL
,	NULL
EDTA	NULL
(	NULL
8	NULL
mm	NULL
)	NULL
,	NULL
sodium	NULL
pyro-phosphate	NULL
(	NULL
0.1	NULL
%	NULL
)	NULL
,	NULL
SDS	NULL
(	NULL
0.2	NULL
%	NULL
)	NULL
and	NULL
heparin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
;	NULL
hybrid-ization	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
68	NULL
¬∞C	NULL
in	NULL
the	NULL
same	NULL
mixture	NULL
,	NULL
but	NULL
the	NULL
concentration	NULL
of	NULL
heparin	NULL
was	NULL
increased	NULL
to	NULL
625	NULL
g/ml	NULL
and	NULL
dextran	NULL
sulphate	NULL
(	NULL
10	NULL
%	NULL
)	NULL
was	NULL
added	NULL
[	NULL
21	NULL
]	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
washed	NULL
once	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
in	NULL
2x	NULL
SSC	NULL
(	NULL
1	NULL
x	NULL
SSC	NULL
is	NULL
0.15	NULL
m-NaC1/0.015	NULL
m-sodium	NULL
citrate	NULL
,	NULL
pH	NULL
7	NULL
)	NULL
,	NULL
once	NULL
with	NULL
0.1	NULL
x	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
68	NULL
¬∞C	NULL
for	NULL
60	NULL
min	NULL
,	NULL
then	NULL
rinsed	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
0.1	NULL
x	NULL
SSC	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
with	NULL
intensifying	NULL
screens	NULL
at	NULL
-80	NULL
¬∞C	NULL
.	NULL

Signal	NULL
intensity	NULL
was	NULL
quantified	NULL
by	NULL
densitometry	NULL
with	NULL
a	NULL
Phar-macia	NULL
LKB	NULL
Ultrascan	NULL
XL	NULL
instrument	NULL
(	NULL
Pharmacia	NULL
,	NULL
Baie	NULL
d'Urfe	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
stripped	NULL
of	NULL
the	NULL
probe	NULL
by	NULL
washing	NULL
for	NULL
60	NULL
min	NULL
with	NULL
0.02	NULL
x	NULL
SSC/0.2	NULL
%	NULL
SDS	NULL
at	NULL
90	NULL
¬∞C	NULL
and	NULL
rehybridized	NULL
.	NULL

In	NULL
order	NULL
to	NULL
assess	NULL
stability	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
10	NULL
min	NULL
after	NULL
stimulation	NULL
with	NULL
LTB	NULL
,	NULL
or	NULL
medium	NULL
to	NULL
arrest	NULL
transcription	NULL
;	NULL
the	NULL
reaction	NULL
was	NULL
stopped	NULL
after	NULL
various	NULL
intervals	NULL
,	NULL
and	NULL
Northern	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
transcription	NULL
in	NULL
vitro	NULL
The	NULL
'in	NULL
vitro	NULL
'	NULL
nuclear	NULL
transcription	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Greenberg	NULL
&	NULL
Bender	NULL
[	NULL
22	NULL
]	NULL
with	NULL
several	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
were	NULL
prepared	NULL
from	NULL
human	NULL
monocytes	NULL
by	NULL
resus-pending	NULL
cells	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
containing	NULL
sucrose	NULL
(	NULL
0.3	NULL
M	NULL
)	NULL
,	NULL
KCl	NULL
(	NULL
60	NULL
mm	NULL
)	NULL
,	NULL
NaCl	NULL
(	NULL
15	NULL
mm	NULL
)	NULL
,	NULL
Hepes	NULL
(	NULL
pH	NULL
7.5	NULL
,	NULL
15	NULL
mm	NULL
)	NULL
,	NULL
EDTA	NULL
(	NULL
2	NULL
mm	NULL
)	NULL
,	NULL
EGTA	NULL
(	NULL
0.5	NULL
mm	NULL
)	NULL
,	NULL
spermine	NULL
(	NULL
0.15	NULL
mm	NULL
)	NULL
,	NULL
spermidine	NULL
(	NULL
0.5	NULL
mm	NULL
)	NULL
,	NULL
mer-captocethanol	NULL
(	NULL
14	NULL
mm	NULL
)	NULL
and	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P40	NULL
,	NULL
followed	NULL
by	NULL
sedimentation	NULL
through	NULL
a	NULL
30	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
sucrose	NULL
solution	NULL
.	NULL

Transcription	NULL
in	NULL
vitro	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
following	NULL
transcription	NULL
mixture	NULL
:	NULL
1x	NULL
buffer	NULL
[	NULL
5x	NULL
buffer	NULL
is	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
,	NULL
SO	NULL
,	NULL
(	NULL
1.5	NULL
)	NULL
/Tris/HCl	NULL
(	NULL
pH	NULL
7.9	NULL
,	NULL
500	NULL
mm	NULL
)	NULL
/MgC1	NULL
,	NULL
(	NULL
20	NULL
mm	NULL
)	NULL
/MnCl	NULL
,	NULL
(	NULL
20	NULL
mm	NULL
)	NULL
/NaCl	NULL
(	NULL
1	NULL
)	NULL
/	NULL
EDTA	NULL
(	NULL
2	NULL
mm	NULL
)	NULL
/phenylmethanesulphonyl	NULL
fluoride	NULL
(	NULL
0.5	NULL
mm	NULL
]	NULL
,	NULL
di-thiothreitol	NULL
(	NULL
1.2	NULL
4M	NULL
)	NULL
,	NULL
GTP	NULL
(	NULL
1	NULL
mm	NULL
)	NULL
,	NULL
ATP	NULL
(	NULL
1	NULL
mm	NULL
)	NULL
,	NULL
CTP	NULL
(	NULL
1	NULL
mm	NULL
)	NULL
,	NULL
creatine	NULL
phosphate	NULL
(	NULL
10	NULL
mm	NULL
)	NULL
,	NULL
RNasin	NULL
(	NULL
20	NULL
units/ml	NULL
)	NULL
and	NULL
glycerol	NULL
(	NULL
29	NULL
%	NULL
,	NULL
v/v	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
150	NULL
4Ci	NULL
of	NULL
[	NULL
x-	NULL
``	NULL
PJUTP	NULL
(	NULL
>	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
.	NULL

The	NULL
radiolabelled	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
chloro-form/phenol	NULL
extraction	NULL
and	NULL
trichloroacetic	NULL
acid/sodium	NULL
pyro-phosphate	NULL
precipitation	NULL
.	NULL

The	NULL
labelled	NULL
nuclear	NULL
RNA	NULL
was	NULL
then	NULL
hybridized	NULL
to	NULL
linearized	NULL
cDNA	NULL
probes	NULL
(	NULL
250	NULL
ng	NULL
)	NULL
that	NULL
were	NULL
immobilized	NULL
on	NULL
Genescreen	NULL
Plus	NULL
membranes	NULL
with	NULL
a	NULL
slot-blot	NULL
apparatus	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
prehybridized	NULL
with	NULL
the	NULL
following	NULL
mixture	NULL
:	NULL
Hepes	NULL
(	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mm	NULL
)	NULL
/NaCl	NULL
(	NULL
0.75	NULL
m	NULL
)	NULL
/formamide	NULL
(	NULL
50	NULL
%	NULL
,	NULL
v/v	NULL
)	NULL
SDS	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
/EDTA	NULL
(	NULL
2	NULL
mm	NULL
)	NULL
/10	NULL
x	NULL
Denhardt	NULL
's	NULL
solution/salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
500	NULL
ug/ml	NULL
)	NULL
/poly	NULL
(	NULL
A	NULL
)	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
,	NULL
for	NULL
2	NULL
days	NULL
.	NULL

Hybrid	NULL
~	NULL
ization	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
4	NULL
days	NULL
in	NULL
the	NULL
same	NULL
mixture	NULL
with	NULL
the	NULL
radiolabelled	NULL
RNA	NULL
;	NULL
the	NULL
membranes	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
for	NULL
2	NULL
weeks	NULL
.	NULL

Nuclear	NULL
factors	NULL
and	NULL
mobility-shift	NULL
assay	NULL
Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
monocytes	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
kindly	NULL
given	NULL
by	NULL
Dr.	NULL
D.	NULL
Hunting	NULL
)	NULL
as	NULL
described	NULL
above	NULL
.	NULL

To	NULL
obtain	NULL
nuclear	NULL
proteins	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
lysed	NULL
by	NULL
repeated	NULL
freeze-thaw	NULL
cycles	NULL
(	NULL
minimum	NULL
three	NULL
)	NULL
,	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
250	NULL
mm-Tris	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
60	NULL
mm-KCl	NULL
,	NULL
1	NULL
mm-dithiothreito	NULL
!	NULL

and	NULL
1	NULL
mm-phenylmethanesul-phonyl	NULL
fluoride	NULL
.	NULL

The	NULL
following	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
was	NULL
used	NULL
:	NULL
with	NULL
the	NULL
complementary	NULL
oligonucleotide	NULL
STGACTCACTGA-CTCAC3	NULL
'	NULL
.	NULL

A	NULL
mutant	NULL
AAP-1	NULL
,	NULL
SGTGATTCATTGATTCAY	NULL
,	NULL
annealed	NULL
to	NULL
its	NULL
complementary	NULL
strand	NULL
,	NULL
STGAATCAATGA-ATCAC3	NULL
'	NULL
,	NULL
and	NULL
an	NULL
irrelevant	NULL
oligonucleotide	NULL
SP-1	NULL
,	NULL
5GGG-CGGGGGCGG3	NULL
'	NULL
,	NULL
annealed	NULL
to	NULL
its	NULL
complementary	NULL
strand	NULL
,	NULL
5CCGCCCCCGCCC3	NULL
'	NULL
,	NULL
were	NULL
used	NULL
for	NULL
competion	NULL
studies	NULL
.	NULL

For	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
the	NULL
*¬∞P-labelled	NULL
probe	NULL
(	NULL
1-2	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
with	NULL
5	NULL
4g	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
in	NULL
binding	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mm-Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1992	NULL
Research	NULL
Communication	NULL
60	NULL
mm-KCl	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
,	NULL
1	NULL
mm-dithiothreitol	NULL
,	NULL
1	NULL
mm-EDTA	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
low-ionic-strength	NULL
4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
-poly-acrylamide	NULL
gel	NULL
with	NULL
Tris/borate	NULL
electrophoresis	NULL
buffer	NULL
(	NULL
TBE	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
The	NULL
proto-oncogenes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

These	NULL
genes	NULL
code	NULL
for	NULL
proteins	NULL
which	NULL
can	NULL
associate	NULL
in	NULL
a	NULL
hetero-dimer	NULL
and	NULL
function	NULL
synergistically	NULL
in	NULL
DNA	NULL
binding	NULL
[	NULL
23	NULL
]	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
LTB	NULL
,	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
proto-oncogenes	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Since	NULL
adherence	NULL
activates	NULL
monocytes	NULL
,	NULL
they	NULL
were	NULL
incubated	NULL
overnight	NULL
,	NULL
after	NULL
their	NULL
isolation	NULL
,	NULL
in	NULL
order	NULL
to	NULL
allow	NULL
them	NULL
to	NULL
return	NULL
to	NULL
their	NULL
baseline	NULL
activity	NULL
.	NULL

Resting	NULL
monocytes	NULL
expressed	NULL
low	NULL
amounts	NULL
of	NULL
c-fos	NULL
mRNA	NULL
and	NULL
substantially	NULL
higher	NULL
amounts	NULL
of	NULL
c-jun	NULL
message	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
these	NULL
baseline	NULL
levels	NULL
varied	NULL
between	NULL
individuals	NULL
,	NULL
as	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
others	NULL
[	NULL
24	NULL
]	NULL
.	NULL

LTB	NULL
,	NULL
augmented	NULL
the	NULL
expression	NULL
of	NULL
c-fos	NULL
mRNA	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
showing	NULL
3-1	NULL
5-fold	NULL
increase	NULL
at	NULL
10~*	NULL
m	NULL
and	NULL
2-S5-fold	NULL
at	NULL
107¬∞	NULL
m	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
;	NULL
lower	NULL
concentrations	NULL
of	NULL
LTB	NULL
,	NULL
did	NULL
not	NULL
consistently	NULL
modulate	NULL
c-fos	NULL
expression	NULL
.	NULL

The	NULL
c-jun	NULL
mRNA	NULL
also	NULL
showed	NULL
increased	NULL
accumulation	NULL
after	NULL
stimulation	NULL
by	NULL
LTB	NULL
,	NULL
at	NULL
the	NULL
same	NULL
concentrations	NULL
.	NULL

Although	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
augmented	NULL
to	NULL
a	NULL
much	NULL
lower	NULL
extent	NULL
(	NULL
1.2-1.5-fold	NULL
)	NULL
,	NULL
the	NULL
increase	NULL
was	NULL
consistently	NULL
reproducible	NULL
(	NULL
Figs	NULL
.	NULL

16	NULL
and	NULL
1c	NULL
)	NULL
.	NULL

The	NULL
accumulation	NULL
of	NULL
mRNA	NULL
of	NULL
both	NULL
genes	NULL
in	NULL
human	NULL
monocytes	NULL
can	NULL
0	NULL
5	NULL
E	NULL
F	NULL
C	NULL
6	NULL
o	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
-	NULL
<	NULL
28	NULL
S	NULL
c-fos	NULL
¬ª	NULL
P	NULL
-	NULL
<	NULL
18	NULL
S	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
w-oxidation	NULL
metabolites	NULL
of	NULL
LTB	NULL
,	NULL
on	NULL
c-fos	NULL
mRNA	NULL
expression	NULL
Total	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
monocytes	NULL
taken	NULL
directly	NULL
after	NULL
overnight	NULL
incubation	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
3x	NULL
10~	NULL
'	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
methanol	NULL
(	NULL
vehicle	NULL
for	NULL
LTB	NULL
,	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
10~¬Æ	NULL
m-LTB	NULL
,	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
0.003	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
acetone	NULL
(	NULL
vehicle	NULL
for	NULL
w-oxidation	NULL
metabolites	NULL
}	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
10~¬Æ	NULL
m-20-OH-LTB	NULL
,	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
10~¬Æ	NULL
m-20-COOH-LTB	NULL
,	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
hybridized	NULL
with	NULL
c-fos-specific	NULL
probe	NULL
and	NULL
exposed	NULL
for	NULL
20	NULL
h	NULL
at	NULL
-80	NULL
¬∞C	NULL
.	NULL

Vol	NULL
.	NULL

282	NULL
627	NULL
be	NULL
augmented	NULL
by	NULL
simple	NULL
physical	NULL
perturbation	NULL
,	NULL
such	NULL
as	NULL
shaking	NULL
the	NULL
cells	NULL
in	NULL
order	NULL
to	NULL
distribute	NULL
the	NULL
intended	NULL
stimulus	NULL
.	NULL

This	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
c	NULL
)	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
(	NULL
lanes	NULL
1	NULL
)	NULL
where	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
rested	NULL
overnight	NULL
and	NULL
directly	NULL
harvested	NULL
without	NULL
further	NULL
disturbance	NULL
expressed	NULL
much	NULL
lower	NULL
levels	NULL
of	NULL
mRNA	NULL
than	NULL
cells	NULL
which	NULL
had	NULL
been	NULL
shaken	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
period	NULL
of	NULL
time	NULL
(	NULL
lanes	NULL
2	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
c-fos	NULL
mRNA	NULL
accumulation	NULL
was	NULL
transient	NULL
and	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
about	NULL
15	NULL
min	NULL
and	NULL
was	NULL
often	NULL
undetectable	NULL
after	NULL
1	NULL
h	NULL
;	NULL
c-jun	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
about	NULL
30	NULL
min	NULL
and	NULL
the	NULL
mRNA	NULL
still	NULL
persisted	NULL
at	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

16	NULL
and	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
time	NULL
of	NULL
appearance	NULL
and	NULL
length	NULL
of	NULL
persistence	NULL
of	NULL
mRNA	NULL
for	NULL
these	NULL
two	NULL
genes	NULL
can	NULL
vary	NULL
with	NULL
cell	NULL
type	NULL
and	NULL
stimulus	NULL
[	NULL
25-27	NULL
]	NULL
.	NULL

Interestingly	NULL
,	NULL
LTB	NULL
,	NULL
failed	NULL
to	NULL
elicit	NULL
either	NULL
c-fos	NULL
or	NULL
c-jun	NULL
expression	NULL
in	NULL
adipogenic	NULL
TAl	NULL
cells	NULL
[	NULL
28	NULL
]	NULL
and	NULL
in	NULL
peripheral-blood	NULL
lymphocytes	NULL
(	NULL
J.	NULL
Stafikova	NULL
,	NULL
unpublished	NULL
work	NULL
)	NULL
.	NULL

Distinct	NULL
signals	NULL
elicit	NULL
different	NULL
kinetics	NULL
of	NULL
proto-oncogene	NULL
activation	NULL
in	NULL
monocytes	NULL
;	NULL
for	NULL
example	NULL
,	NULL
macro-phage	NULL
colony-stimulating	NULL
factor	NULL
augments	NULL
c-jun	NULL
mRNA	NULL
within	NULL
30	NULL
min	NULL
,	NULL
but	NULL
the	NULL
expression	NULL
returns	NULL
to	NULL
baseline	NULL
within	NULL
60	NULL
min	NULL
,	NULL
whereas	NULL
in	NULL
alveolar	NULL
macrophages	NULL
c-fos	NULL
reaches	NULL
a	NULL
peak	NULL
at	NULL
60	NULL
min	NULL
after	NULL
macrophage-colony-stimulating-factor	NULL
stimulation	NULL
[	NULL
29	NULL
]	NULL
.	NULL

Conversely	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor	NULL
a	NULL
induced	NULL
a	NULL
prolonged	NULL
expression	NULL
of	NULL
c-jun	NULL
for	NULL
up	NULL
to	NULL
8	NULL
h	NULL
,	NULL
but	NULL
c-fos	NULL
expression	NULL
is	NULL
transient	NULL
,	NULL
returning	NULL
to	NULL
baseline	NULL
within	NULL
60	NULL
min	NULL
[	NULL
27,30,31	NULL
]	NULL
,	NULL
illustrating	NULL
that	NULL
diverse	NULL
signalling	NULL
pathways	NULL
may	NULL
result	NULL
in	NULL
potentially	NULL
differential	NULL
effects	NULL
of	NULL
the	NULL
oncogene	NULL
products	NULL
.	NULL

Human	NULL
neutrophils	NULL
can	NULL
rapidly	NULL
metabolize	NULL
LTB	NULL
,	NULL
by	NULL
w-oxid-ation	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
20-OH-LTB	NULL
,	NULL
and	NULL
20-COOH-LTB	NULL
,	NULL
[	NULL
32	NULL
]	NULL
.	NULL

These	NULL
metabolites	NULL
had	NULL
only	NULL
20-30	NULL
%	NULL
and	NULL
0-3	NULL
%	NULL
activity	NULL
respectively	NULL
on	NULL
c-fos	NULL
expression	NULL
,	NULL
compared	NULL
with	NULL
LTB	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
LTB	NULL
,	NULL
molecule	NULL
was	NULL
necessary	NULL
for	NULL
optimal	NULL
activity	NULL
.	NULL

A	NULL
comparable	NULL
level	NULL
of	NULL
activity	NULL
for	NULL
these	NULL
metabolites	NULL
has	NULL
been	NULL
found	NULL
in	NULL
other	NULL
systems	NULL
[	NULL
33,34	NULL
]	NULL
.	NULL

Both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
control	NULL
of	NULL
c-fos	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
has	NULL
been	NULL
described	NULL
.	NULL

For	NULL
example	NULL
,	NULL
phorbol-ester-stimulated	NULL
c-fos	NULL
mRNA	NULL
increase	NULL
is	NULL
related	NULL
solely	NULL
to	NULL
increased	NULL
transcription	NULL
,	NULL
whereas	NULL
cycloheximide-induced	NULL
increase	NULL
results	NULL
from	NULL
both	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
and	NULL
prolongation	NULL
of	NULL
the	NULL
half-life	NULL
of	NULL
c-fos	NULL
mRNA	NULL
[	NULL
35	NULL
]	NULL
.	NULL

We	NULL
investigated	NULL
whether	NULL
stabilization	NULL
of	NULL
the	NULL
c-fos	NULL
message	NULL
contributed	NULL
to	NULL
the	NULL
mRNA	NULL
accumulation	NULL
observed	NULL
in	NULL
LTB	NULL
,	NULL
-stimulated	NULL
>	NULL
monocytes	NULL
.	NULL

We	NULL
measured	NULL
the	NULL
stability	NULL
of	NULL
c-fos	NULL
mRNA	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
LTB	NULL
,	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
adding	NULL
actinomycin	NULL
D	NULL
to	NULL
block	NULL
the	NULL
RNA	NULL
transcription	NULL
de	NULL
novo	NULL
.	NULL

Although	NULL
the	NULL
c-fos	NULL
mRNA	NULL
half-life	NULL
can	NULL
be	NULL
extended	NULL
in	NULL
monocytes	NULL
by	NULL
fMet-Leu-Phe	NULL
,	NULL
a	NULL
chemotactic	NULL
peptide	NULL
[	NULL
24	NULL
]	NULL
,	NULL
the	NULL
chemotactic	NULL
lipid	NULL
LTB	NULL
,	NULL
failed	NULL
to	NULL
stabilize	NULL
the	NULL
message	NULL
for	NULL
c-fos	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
c-jun	NULL
mRNA	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
LTB	NULL
,	NULL
stimulation	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
LTB	NULL
,	NULL
did	NULL
not	NULL
stabilize	NULL
the	NULL
proto-oncogene	NULL
mRNA	NULL
,	NULL
we	NULL
performed	NULL
'in	NULL
vitro	NULL
'	NULL
nuclear	NULL
transcription	NULL
(	NULL
run-on	NULL
)	NULL
assays	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
transcriptional	NULL
mechanisms	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
expression	NULL
by	NULL
LT	NULL
B	NULL
,	NULL
.	NULL

Both	NULL
c-jun	NULL
and	NULL
c-fos	NULL
genes	NULL
were	NULL
actively	NULL
transcribed	NULL
in	NULL
unstimulated	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
;	NULL
NS	NULL
)	NULL
,	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
[	NULL
24,30	NULL
]	NULL
.	NULL

Stimulation	NULL
with	NULL
LTB	NULL
,	NULL
(	NULL
10	NULL
nm	NULL
)	NULL
increased	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
7	NULL
and	NULL
the	NULL
c-jun	NULL
gene	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
1.8	NULL
(	NULL
mean	NULL
for	NULL
six	NULL
separate	NULL
experiments	NULL
)	NULL
(	NULL
Figs	NULL
.	NULL

4a	NULL
and	NULL
46	NULL
)	NULL
.	NULL

Some	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
forskolin	NULL
,	NULL
may	NULL
enhance	NULL
gene	NULL
expression	NULL
without	NULL
producing	NULL
an	NULL
increase	NULL
in	NULL
nuclear	NULL
AP-1	NULL
DNA	NULL
binding	NULL
,	NULL
whereas	NULL
the	NULL
cytokine	NULL
interleukin-1	NULL
induces	NULL
both	NULL
[	NULL
36	NULL
]	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
the	NULL
augmented	NULL
expression	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
in	NULL
LTB	NULL
,	NULL
-stimulated	NULL
monocytes	NULL
was	NULL
associated	NULL
with	NULL
increased	NULL
DNA-binding	NULL
activity	NULL
.	NULL

DNA-nuclear-protein	NULL
interactions	NULL
were	NULL
monitored	NULL
with	NULL
a	NULL
standard	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
.	NULL

Unstimulated	NULL
monocytes	NULL
contained	NULL
active	NULL
factors	NULL
628	NULL
Level	NULL
of	NULL
c-fos	NULL
mRNA	NULL
(	NULL
%	NULL
of	NULL
that	NULL
at	NULL
zero	NULL
time	NULL
)	NULL
--	NULL
r	NULL
=	NULL
--	NULL
--	NULL
r	NULL
--	NULL
--	NULL
--	NULL
-	NULL
L	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
Time	NULL
(	NULL
min	NULL
}	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Analysis	NULL
of	NULL
c-fos	NULL
mRNA	NULL
stability	NULL
in	NULL
monocytes	NULL
treated	NULL
with	NULL
LTB	NULL
,	NULL
Monocytes	NULL
were	NULL
treated	NULL
with	NULL
vehicle	NULL
(	NULL
methanol	NULL
;	NULL
3	NULL
x	NULL
(	NULL
v/v	NULL
)	NULL
;	NULL
control	NULL
,	NULL
@	NULL
)	NULL
or	NULL
m-LTB	NULL
,	NULL
for	NULL
10	NULL
min	NULL
(	NULL
(	NULL
]	NULL
)	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
c-fos	NULL
mRNA	NULL
were	NULL
determined	NULL
before	NULL
(	NULL
zero	NULL
time	NULL
)	NULL
and	NULL
at	NULL
10	NULL
min	NULL
intervals	NULL
after	NULL
actinomycin	NULL
D	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
c-fos	NULL
mRNA	NULL
after	NULL
actinomycin	NULL
D	NULL
treatment	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
level	NULL
in	NULL
monocytes	NULL
at	NULL
zero	NULL
time	NULL
.	NULL

Results	NULL
are	NULL
means	NULL
for	NULL
three	NULL
experiments	NULL
.	NULL

(	NULL
a	NULL
)	NULL
NS	NULL
LTB4	NULL
c-fos	NULL
#	NULL
c-jun	NULL
Q	NULL
|	NULL
¬´	NULL
BR	NULL
GAPDH	NULL
(	NULL
b	NULL
)	NULL
&	NULL
t	NULL
0	NULL
ho	NULL
=	NULL
]	NULL
o	NULL
__	NULL
densitometry	NULL
ratio	NULL
c-jun/GAPDH	NULL
densitometry	NULL
ratio	NULL
o	NULL
Control	NULL
‚Äù	NULL
Control	NULL
10	NULL
%	NULL
Mm-LTB4	NULL
10¬∞	NULL
m-LTB	NULL
,	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
gene	NULL
transcription	NULL
in	NULL
human	NULL
monocytes	NULL
stimulated	NULL
with	NULL
107¬∞	NULL
m-LTB	NULL
,	NULL
Monocytes	NULL
were	NULL
incubated	NULL
without	NULL
(	NULL
NS	NULL
or	NULL
control	NULL
)	NULL
or	NULL
with	NULL
10~¬Æ	NULL
m-LTB	NULL
,	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
and	NULL
newly	NULL
elongated	NULL
*¬∞P-labelled	NULL
RNA	NULL
transcripts	NULL
were	NULL
hybridized	NULL
to	NULL
immobilized	NULL
c-fos	NULL
and	NULL
c-jun	NULL
cDNA	NULL
.	NULL

(	NULL
a	NULL
)	NULL
A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Data	NULL
are	NULL
presented	NULL
as	NULL
ratios	NULL
of	NULL
the	NULL
densitometric	NULL
units	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
over	NULL
glyceraldehyde-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
and	NULL
represent	NULL
the	NULL
means	NULL
for	NULL
six	NULL
separate	NULL
experiments	NULL
.	NULL

that	NULL
bound	NULL
to	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
but	NULL
the	NULL
binding	NULL
activity	NULL
was	NULL
increased	NULL
after	NULL
stimulation	NULL
with	NULL
LTB	NULL
,	NULL
at	NULL
concentrations	NULL
of	NULL
1	NULL
4m	NULL
and	NULL
10	NULL
nm	NULL
,	NULL
but	NULL
not	NULL
10	NULL
fm	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
reaction	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
unlabelled	NULL
oligonucleotide	NULL
readily	NULL
competed	NULL
with	NULL
the	NULL
labelled	NULL
oligonucleotide	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
labelled	NULL
DNA-protein	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
,	NULL
lanes	NULL
5-6	NULL
)	NULL
.	NULL

The	NULL
second	NULL
band	NULL
in	NULL
lanes	NULL
1-4	NULL
did	NULL
not	NULL
bind	NULL
with	NULL
specificity	NULL
,	NULL
as	NULL
when	NULL
it	NULL
was	NULL
present	NULL
it	NULL
could	NULL
be	NULL
competed	NULL
for	NULL
by	NULL
unlabelled	NULL
SP-1	NULL
oligonucleotide	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
AP-1	NULL
binding	NULL
by	NULL
nuclear	NULL
extracts	NULL
was	NULL
further	NULL
addressed	NULL
by	NULL
comparing	NULL
the	NULL
degree	NULL
of	NULL
mobility	NULL
of	NULL
nuclear-protein	NULL
extracts	NULL
from	NULL
monocytes	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
(	NULL
b	NULL
)	NULL
,	NULL
both	NULL
Research	NULL
Communication	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

LTB	NULL
,	NULL
-induced	NULL
AP-1	NULL
binding	NULL
activity	NULL
(	NULL
a	NULL
)	NULL
Effect	NULL
of	NULL
LTB	NULL
,	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
AP-1	NULL
element	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
control	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
LTB	NULL
,	NULL
-stimulated	NULL
monocytes	NULL
(	NULL
lane	NULL
2	NULL
,	NULL
107¬∞	NULL
m	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
10~¬Æ	NULL
m	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
10~	NULL
``	NULL
M	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
**P-end-labelled	NULL
double-stranded	NULL
AP-1	NULL
oligonucleotide	NULL
.	NULL

In	NULL
lanes	NULL
5-7	NULL
the	NULL
nuclear	NULL
extracts	NULL
and	NULL
labelled	NULL
oligonucleotide	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabelled	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
5	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
107¬∞	NULL
m-LTB	NULL
,	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
10~'*	NULL
M-LTB	NULL
,	NULL
)	NULL
.	NULL

(	NULL
6	NULL
)	NULL
Nuclear	NULL
protein-AP-1	NULL
complexes	NULL
isolated	NULL
from	NULL
monocytes	NULL
and	NULL
HeLa	NULL
cells	NULL
migrate	NULL
with	NULL
a	NULL
similar	NULL
degree	NULL
of	NULL
retardation	NULL
of	NULL
mobility	NULL
:	NULL
M	NULL
,	NULL
monocyte	NULL
extracts	NULL
;	NULL
H	NULL
,	NULL
extract	NULL
from	NULL
HeLa	NULL
cells	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Nuclear-protein	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
labelled	NULL
AP-1	NULL
oligonucleotide	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
of	NULL
competing	NULL
unlabelled	NULL
double-stranded	NULL
oligonucleo-tides	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
50-fold	NULL
excess	NULL
of	NULL
AAP-1	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
50-fold	NULL
excess	NULL
of	NULL
SP-1	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
100-fold	NULL
excess	NULL
of	NULL
AAP-1	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
100-fold	NULL
excess	NULL
of	NULL
SP-1	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
oligonucleotide	NULL
(	NULL
lower	NULL
part	NULL
of	NULL
each	NULL
lane	NULL
)	NULL
in	NULL
low-ionic-strength	NULL
4	NULL
%	NULL
-	NULL
(	NULL
w/v	NULL
)	NULL
-polyacrylamide	NULL
gels	NULL
.	NULL

complexes	NULL
show	NULL
similar	NULL
degree	NULL
of	NULL
retardation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
mutant	NULL
AP-1	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
with	NULL
AP-1	NULL
at	NULL
50-100-fold	NULL
excess	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

5¬¢	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
SP-1	NULL
binding	NULL
site	NULL
also	NULL
did	NULL
not	NULL
decrease	NULL
AP-1	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

Sc	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
DNA-binding	NULL
activity	NULL
in	NULL
monocytes	NULL
stimulated	NULL
with	NULL
LTB	NULL
,	NULL
is	NULL
specific	NULL
for	NULL
AP-1	NULL
.	NULL

It	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
unstimulated	NULL
monocytes	NULL
exhibited	NULL
AP-1-binding	NULL
activity	NULL
,	NULL
since	NULL
the	NULL
expression	NULL
of	NULL
c-jun	NULL
is	NULL
constitutively	NULL
high	NULL
and	NULL
JUN/JUN	NULL
homodimers	NULL
bind	NULL
to	NULL
the	NULL
consensus	NULL
AP-1	NULL
sequence	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
FOS/JUN	NULL
heterodimers	NULL
[	NULL
34,37	NULL
]	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
AP-1	NULL
binding	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
LTB	NULL
,	NULL
monocytes	NULL
could	NULL
be	NULL
the	NULL
result	NULL
of	NULL
greater	NULL
FOS	NULL
participation	NULL
,	NULL
due	NULL
to	NULL
increased	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
LTB	NULL
,	NULL
augments	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
proto-oncogenes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
.	NULL

Since	NULL
the	NULL
protein	NULL
products	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
factors	NULL
which	NULL
may	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
1992	NULL
Research	NULL
Communication	NULL
other	NULL
genes	NULL
,	NULL
these	NULL
data	NULL
give	NULL
the	NULL
first	NULL
indication	NULL
that	NULL
LTB	NULL
,	NULL
may	NULL
modulate	NULL
monocyte	NULL
function	NULL
,	NULL
such	NULL
as	NULL
cytokine	NULL
gene	NULL
expression	NULL
,	NULL
by	NULL
influencing	NULL
the	NULL
production	NULL
or	NULL
composition	NULL
of	NULL
transcriptional	NULL
factors	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
C.	NULL
Asselin	NULL
for	NULL
sharing	NULL
not	NULL
only	NULL
his	NULL
expertise	NULL
and	NULL
time	NULL
but	NULL
also	NULL
his	NULL
probes	NULL
and	NULL
acknowledge	NULL
the	NULL
technical	NULL
expertise	NULL
of	NULL
S.	NULL
B√©dard	NULL
,	NULL
P.	NULL
Champagne	NULL
and	NULL
C.	NULL
Fouquet	NULL
.	NULL

We	NULL
also	NULL
wish	NULL
to	NULL
thank	NULL
C.	NULL
Jacques	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
Canada	NULL
and	NULL
the	NULL
Fonds	NULL
de	NULL
la	NULL
Recherche	NULL
en	NULL
Sant√©	NULL
du	NULL
Qu√©bec	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ford-Hutchinson	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Bray	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Doig	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Shipley	NULL
,	NULL
M.	NULL
E.	NULL
&	NULL
Smith	NULL
,	NULL
H.	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
286	NULL
,	NULL
264-265	NULL
.	NULL

Rola-Pleszezynski	NULL
,	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
10	NULL
,	NULL
302-307	NULL
.	NULL

Rola-Pleszcezynski	NULL
,	NULL
M.	NULL
&	NULL
Lemaire	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

135	NULL
,	NULL
3958-3961	NULL
.	NULL

Rola-Pleszcezynski	NULL
,	NULL
M.	NULL
,	NULL
Chavaillaz	NULL
,	NULL
P.-A	NULL
.	NULL

&	NULL
Lemaire	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Prostaglandins	NULL
Leukotrienes	NULL
Med	NULL
.	NULL

23	NULL
,	NULL
207-210	NULL
.	NULL

Rola-Pleszezynski	NULL
,	NULL
M.	NULL
,	NULL
Bouvrette	NULL
,	NULL
L.	NULL
,	NULL
Gingras	NULL
,	NULL
D.	NULL
&	NULL
Girard	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

139	NULL
,	NULL
513-517	NULL
.	NULL

Goodwin	NULL
,	NULL
J.	NULL
S.	NULL
&	NULL
Atluru	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

136	NULL
,	NULL
3455-3460	NULL
.	NULL

Gagnon	NULL
,	NULL
L.	NULL
,	NULL
Filion	NULL
,	NULL
L.	NULL
G.	NULL
,	NULL
Dubois	NULL
,	NULL
C.	NULL
&	NULL
Rola-Pleszezynski	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Agents	NULL
Actions	NULL
26	NULL
,	NULL
141-147	NULL
.	NULL

Gagnon	NULL
,	NULL
L.	NULL
,	NULL
Filion	NULL
,	NULL
L.	NULL
G.	NULL
&	NULL
Rola-Pleszezynski	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Immunopathol	NULL
.	NULL

Pharmacol	NULL
.	NULL

2	NULL
,	NULL
155-163	NULL
.	NULL

Wong	NULL
,	NULL
G.	NULL
G.	NULL
&	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
9	NULL
,	NULL
137-139	NULL
.	NULL

Dubois	NULL
,	NULL
C.	NULL
,	NULL
Bissonnette	NULL
,	NULL
E.	NULL
&	NULL
Rola-Pleszezynski	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

143	NULL
,	NULL
964-971	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Turetskaya	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Kuprash	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Drouet	NULL
,	NULL
C.	NULL
&	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
of	NULL
Cytokines	NULL
(	NULL
Oppenheim	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Powanda	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Kluger	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Dinarello	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
vol	NULL
.	NULL

10A	NULL
,	NULL
pp	NULL
.	NULL

25-30	NULL
,	NULL
Wiley-Liss	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Ray	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
in	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
of	NULL
cytokines	NULL
(	NULL
Oppenheim	NULL
,	NULL
J.J.	NULL
,	NULL
Powanda	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Kluger	NULL
,	NULL
M.J.	NULL
&	NULL
Dinarello	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
vol	NULL
.	NULL

10A	NULL
,	NULL
pp	NULL
.	NULL

37-43	NULL
,	NULL
Wiley-Liss	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Chiu	NULL
,	NULL
E.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Meek	NULL
,	NULL
J.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

54	NULL
,	NULL
541-552	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
&	NULL
Ziff	NULL
,	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
336-646	NULL
.	NULL

Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Volalas	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
&	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1687-1699	NULL
Received	NULL
24	NULL
October	NULL
1991/10	NULL
December	NULL
1991	NULL
;	NULL
accepted	NULL
14	NULL
January	NULL
1992	NULL
Vol	NULL
.	NULL

282	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

629	NULL
¬´	NULL
Sassone-Corsi	NULL
,	NULL
P	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
,	NULL
Kamps	NULL
,	NULL
M.	NULL
&	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

54	NULL
,	NULL
553-560	NULL
.	NULL

Sonnenberg	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

&	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1622-1625	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlichand	NULL
,	NULL
P.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

49	NULL
,	NULL
729-739	NULL
.	NULL

Boyum	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1968	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

(	NULL
Suppl	NULL
.	NULL
)	NULL

21	NULL
,	NULL
77-80	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
&	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Annal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
.	NULL

Singh	NULL
,	NULL
L.	NULL
&	NULL
Jones	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
5627-5638	NULL
.	NULL

Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
&	NULL
Bender	NULL
,	NULL
T.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
vol	NULL
.	NULL

1	NULL
(	NULL
Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Struhl	NULL
,	NULL
K.	NULL
,	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
pp	NULL
.	NULL

4.10.1.-4.10.7	NULL
,	NULL
Wiley	NULL
and	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
Halazonetis	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
&	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

55	NULL
,	NULL
917-924	NULL
Ho	NULL
,	NULL
Y.-S.	NULL
,	NULL
Lee	NULL
,	NULL
W.	NULL
M.	NULL
F.	NULL
&	NULL
Snyderman	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165	NULL
,	NULL
1524-1538	NULL
Mollinedo	NULL
,	NULL
F.	NULL
,	NULL
Vaquerizo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Naranjo	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

273	NULL
,	NULL
477-479	NULL
Squinto	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Block	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Braquet	NULL
,	NULL
P.	NULL
&	NULL
Bazan	NULL
,	NULL
N.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Neurosci	NULL
.	NULL

Res	NULL
.	NULL

24	NULL
,	NULL
558-566	NULL
Miller	NULL
,	NULL
R.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
&	NULL
Burckhardt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
312	NULL
,	NULL
716-720	NULL
Haliday	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Ramesha	NULL
,	NULL
C.	NULL
S.	NULL
&	NULL
Ringold	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
109-115	NULL
Schaberg	NULL
,	NULL
T.	NULL
&	NULL
Filderman	NULL
,	NULL
A.	NULL
E.	NULL
(	NULL
1990	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

259	NULL
,	NULL
L144-L150	NULL
Mufson	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
2333-2339	NULL
Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojkier	NULL
,	NULL
M.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
337	NULL
,	NULL
661-663	NULL
Hansson	NULL
,	NULL
G.	NULL
,	NULL
Lindgren	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Dahlen	NULL
,	NULL
$	NULL
.-E.	NULL
,	NULL
Hedqvist	NULL
,	NULL
P.	NULL
&	NULL
Samuelsson	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

130	NULL
,	NULL
107-112	NULL
Camp	NULL
,	NULL
R.	NULL
D.	NULL
R.	NULL
,	NULL
Woolard	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Mallet	NULL
,	NULL
A.	NULL
I	NULL
.	NULL

&	NULL
Fincham	NULL
,	NULL
N.	NULL
J	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Prostaglandins	NULL
23	NULL
,	NULL
631-641	NULL
Jubitz	NULL
,	NULL
W.	NULL
,	NULL
Radmark	NULL
,	NULL
O.	NULL
,	NULL
Maimsten	NULL
,	NULL
C.	NULL
,	NULL
Hanson	NULL
,	NULL
G.	NULL
,	NULL
Lindgren	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Palmblad	NULL
,	NULL
J.	NULL
,	NULL
Ud√©n	NULL
,	NULL
A.-M.	NULL
&	NULL
Samuelsson	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257	NULL
,	NULL
6106-6110	NULL
Sariban	NULL
,	NULL
E.	NULL
,	NULL
Luebbers	NULL
,	NULL
R.	NULL
&	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
340-346	NULL
Chedid	NULL
,	NULL
M.	NULL
,	NULL
Yoza	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Brooks	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Mizel	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
867-873	NULL
Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
&	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

55	NULL
,	NULL
907-915	NULL

